When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ETTX - Entasis launches late-stage study of antibiotic combo
Entasis Therapeutics Holdings Inc.
Entasis Therapeutics (ETTX) initiates a Phase 3 clinical trial, ATTACK, evaluating ETX2514SUL, a fixed-dose combination of its broad-spectrum ?-lactamase inhibitor ETX2514 with sulbactam, for the treatment of patients with pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii,a Gram-negative bacterium.
More news on: Entasis Therapeutics, Zai Lab Limited, Healthcare stocks news, Stocks on the move,